Filing Details
- Accession Number:
- 0001209191-16-107452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-09 18:40:42
- Reporting Period:
- 2016-03-07
- Filing Date:
- 2016-03-09
- Accepted Time:
- 2016-03-09 18:40:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1438133 | Tandem Diabetes Care Inc | TNDM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1365369 | F John Sheridan | C/O Tandem Diabetes Care, Inc., 11045 Roselle Street San Diego CA 92121 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-07 | 4,000 | $1.11 | 9,295 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-03-07 | 4,000 | $10.01 | 5,295 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2016-03-07 | 4,000 | $0.00 | 4,000 | $1.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
106,040 | 2014-02-25 | 2023-04-23 | No | 4 | M | Direct |
Footnotes
- The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 3, 2015, in multiple transactions at prices ranging from $10.00 to $10.09. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
- The option became 25% exercisable on 2/25/2014 and in 36 equal monthly installments thereafter.